Sudan’s protracted fighting has sharply increased the cost and scarcity of medicines, forcing many patients with chronic conditions to make stark choices between purchasing essential drugs and meeting basic needs such as food. Pharmacies and clinics in several areas report shortages of common treatments, while people reliant on regular medications say they are cutting doses or stopping treatment entirely because they cannot afford them.
Disrupted supply chains and strained services
The conflict has disrupted transportation and logistics networks that normally bring medicines into cities and rural areas, and interruptions to public services have hampered the ability of health facilities to maintain stocks. Health clinics that continue to operate are facing growing pressure as displaced populations seek care and as routine treatment regimens are interrupted, increasing the workload on already stretched staff.
Economic impact on patients
Rising prices, reduced availability and broader economic stress have compounded the problem, leaving families with limited options. For people with conditions such as diabetes, hypertension or other long‑term illnesses, skipping medication can lead to worsening disease, complications and higher rates of hospitalisation, health professionals warn. Those without reliable access to care are also more vulnerable to acute episodes that require emergency treatment.
Humanitarian response and access challenges
Humanitarian organisations are attempting to scale up support, but access constraints, security risks and the scale of need complicate delivery of medical supplies and assistance. Aid agencies say that sustained access to affected populations, predictable funding and safe supply corridors will be necessary to prevent further deterioration in the health of chronically ill people across conflict-affected areas.
The situation underscores the wider humanitarian toll of the conflict beyond immediate casualties: disruption of routine health services and medicine supply chains can produce long‑term public health consequences and increase preventable morbidity and mortality among those with chronic diseases.